98 related articles for article (PubMed ID: 2797345)
1. Moderately proteinuric IgA nephropathy: prognostic prediction of individual clinical courses and steroid therapy in progressive cases.
Kobayashi Y; Hiki Y; Fujii K; Kurokawa A; Tateno S
Nephron; 1989; 53(3):250-6. PubMed ID: 2797345
[TBL] [Abstract][Full Text] [Related]
2. Steroid therapy in IgA nephropathy: a retrospective study in heavy proteinuric cases.
Kobayashi Y; Fujii K; Hiki Y; Tateno S; Kurokawa A; Kamiyama M
Nephron; 1988; 48(1):12-7. PubMed ID: 3340251
[TBL] [Abstract][Full Text] [Related]
3. Steroid therapy during the early stage of progressive IgA nephropathy. A 10-year follow-up study.
Kobayashi Y; Hiki Y; Kokubo T; Horii A; Tateno S
Nephron; 1996; 72(2):237-42. PubMed ID: 8684533
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic significance of persistent massive proteinuria in progressive IgA nephropathy--a long-term follow-up study].
Kokubo T; Hiki Y; Tateno S; Kobayashi Y
Nihon Jinzo Gakkai Shi; 1994 Jul; 36(7):823-31. PubMed ID: 8072220
[TBL] [Abstract][Full Text] [Related]
6. Steroid therapy in IgA nephropathy: a prospective pilot study in moderate proteinuric cases.
Kobayashi Y; Fujii K; Hiki Y; Tateno S
Q J Med; 1986 Oct; 61(234):935-43. PubMed ID: 3628707
[TBL] [Abstract][Full Text] [Related]
7. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria.
Uzu T; Harada T; Ko M; Yamato M; Takahara K; Yamauchi A
Clin Exp Nephrol; 2003 Sep; 7(3):210-4. PubMed ID: 14586717
[TBL] [Abstract][Full Text] [Related]
8. IgA nephropathy: heterogeneous clinical pictures and steroid therapy in progressive cases.
Kobayashi Y; Hiki Y; Fujii K; Kurokawa A; Kamiyana M; Tateno S
Semin Nephrol; 1987 Dec; 7(4):382-5. PubMed ID: 3445022
[No Abstract] [Full Text] [Related]
9. Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy.
Yagi K; Okada M; Yanagida H; Kuwajima H; Ikeda M; Sugimoto K; Takemura T
Clin Exp Nephrol; 2003 Dec; 7(4):270-4. PubMed ID: 14712355
[TBL] [Abstract][Full Text] [Related]
10. Predictors for progression in immunoglobulin A nephropathy with significant proteinuria.
Hwang HS; Kim BS; Shin YS; Yoon HE; Song JC; Choi BS; Park CW; Yang CW; Kim YS; Bang BK
Nephrology (Carlton); 2010 Mar; 15(2):236-41. PubMed ID: 20470285
[TBL] [Abstract][Full Text] [Related]
11. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
Manno C; Torres DD; Rossini M; Pesce F; Schena FP
Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
[TBL] [Abstract][Full Text] [Related]
12. Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy.
Komatsu H; Fujimoto S; Hara S; Sato Y; Yamada K; Eto T; Nakao H
Ren Fail; 2005; 27(1):45-52. PubMed ID: 15717634
[TBL] [Abstract][Full Text] [Related]
13. Nephrotic range proteinuria--a good predictive index of disease in IgA nephropathy?
Lai KN; Ho CP; Chan KW; Yan KW; Lai FM; Vallance-Owen J
Q J Med; 1985 Oct; 57(222):677-88. PubMed ID: 4080957
[TBL] [Abstract][Full Text] [Related]
14. Treatment of IgA nephropathy.
Pozzi C
J Nephrol; 2016 Feb; 29(1):21-5. PubMed ID: 26577268
[TBL] [Abstract][Full Text] [Related]
15. Comparison of steroids and angiotensin receptor blockers for patients with advanced IgA nephropathy and impaired renal function.
Moriyama T; Amemiya N; Ochi A; Tsuruta Y; Shimizu A; Itabashi M; Takei T; Uchida K; Nitta K
Am J Nephrol; 2011; 34(3):233-40. PubMed ID: 21778707
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
Kang Z; Li Z; Duan C; Wu T; Xun M; Ding Y; Zhang Y; Zhang L; Yin Y
Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive therapy in patients with IgA nephropathy.
Peters HP; van den Brand JA; Berger SP; Wetzels JF
Neth J Med; 2015 Jul; 73(6):284-9. PubMed ID: 26228193
[TBL] [Abstract][Full Text] [Related]
18. Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection.
Riispere Ž; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
BMC Nephrol; 2017 Mar; 18(1):89. PubMed ID: 28292274
[TBL] [Abstract][Full Text] [Related]
19. The influence of pregnancy on the long-term renal prognosis of IgA nephropathy.
Abe S
Clin Nephrol; 1994 Feb; 41(2):61-4. PubMed ID: 8004830
[TBL] [Abstract][Full Text] [Related]
20. [Comparative studies of clinicopathological findings in patients with adult and juvenile onset of IgA nephropathy].
Yaguchi Y; Tomino Y; Nakamura T; Funabiki K; Shirato I; Ebiiiara I; Nakayama S; Koide H
Nihon Jinzo Gakkai Shi; 1989 Jul; 31(7):729-33. PubMed ID: 2585826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
